GRAIL, Inc. (GRAL)
(Delayed Data from NSDQ)
$14.04 USD
-0.01 (-0.07%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $14.03 -0.01 (-0.07%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
GRAL 14.04 -0.01(-0.07%)
Will GRAL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GRAL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for GRAL
GRAIL's Potential Turnaround: Seeking FDA Approval For Galleri
European Court Rules In Favor Of Illumina In Fight Against Probe Into Grail Deal, Asks Not To Pay $478M Fine
Illumina wins legal battle over Grail deal in EU; avoids €432M fine
GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)
Results of GRAIL's Galleri? Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology